Component
Human VEGFA
Context-specific entity; species, compartment and exposure are stated on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The 0.5 mM silicon preparation increased VEGFA expression in HUVECs with or without the tested peroxide challenge.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human endothelial cultures; sodium-metasilicate-derived preparation.
- limitations
- Expression association does not establish direct activation or clinical angiogenesis.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A distinct vascular regulator changed after exposure.
- primary_references
- Ionic silicon improves endothelial cells' survival under toxic oxidative stress by overexpressing angiogenic markers and antioxidant enzymes. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30062712/ · DOI 10.1002/term.2744
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 536–542
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human endothelial cultures; sodium-metasilicate-derived preparation. · source_derived_draft · unverified_draft
## silica-endothelial-marker-human-vegfa A distinct vascular regulator changed after exposure. The 0.5 mM silicon preparation increased VEGFA expression in HUVECs with or without the tested peroxide challenge. Model: Human endothelial cultures; sodium-metasilicate-derived preparation. Limitations: Expression association does not establish direct activation or clinical angiogenesis. Evidence access: Primary full text Ionic silicon improves endothelial cells' survival under toxic oxidative stress by overexpressing angiogenic markers and antioxidant enzymes. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30062712/ · DOI 10.1002/term.2744
Complete structured claim and evidence
Where it participates (unsigned role)
Microcarriers releasing silicon and loaded VEGF increased endothelial migration and tubular networking.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human HUVECs; engineered local-release formulation.
- limitations
- Not evidence of oral silica/VEGF supplementation or a universal synergy.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A tested growth-factor combination promoted vascular-cell behavior.
- primary_references
- Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEGF. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27918936/ · DOI 10.1016/j.biomaterials.2016.11.053
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 280–286
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human HUVECs; engineered local-release formulation. · source_derived_draft · unverified_draft
## silica-microcarrier-vegf A tested growth-factor combination promoted vascular-cell behavior. Microcarriers releasing silicon and loaded VEGF increased endothelial migration and tubular networking. Model: Human HUVECs; engineered local-release formulation. Limitations: Not evidence of oral silica/VEGF supplementation or a universal synergy. Evidence access: Primary abstract Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEGF. · 2017 · https://pubmed.ncbi.nlm.nih.gov/27918936/ · DOI 10.1016/j.biomaterials.2016.11.053
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.